skip to Main Content

Publications 2013

A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity.

Bianchi E, Carrington PE, Ingallinella P, Finotto M, Santoprete A, Petrov A, Eiermann G, Kosinski J, Marsh DJ, Pocai A, SinhaRoy R, Pessi A. (2013)
Bioorg Med Chem. 2013 Nov 15;21(22):7064-73.

More info on PubMed.gov

A transgenic minipig model of Huntington’s Disease

Baxa M, Hruska-Plochan M, Juhas S, Vodicka P, Pavlok A, Juhasova J, Miyanohara A, Nejime T, Klima J, Macakova M, Marsala S, Weiss A, Kubickova S, Musilova P, Vrtel R, Sontag EM, Thompson LM, Schier J, Hansikova H, Howland DS, Cattaneo E, DiFiglia M, Marsala M, Motlik J. (2013)
J Huntingtons Dis. 2013;2(1):47-68.

More info on PubMed.gov

Further molecular characterisation of the OVT73 transgenic sheep model of Huntington’s disease identifies cortical aggregates.

Huntington’s Disease Sheep Collaborative Research Group, Reid SJ, Patassini S, Handley RR, Rudiger SR, McLaughlan CJ, Osmand A, Jacobsen JC, Morton AJ, Weiss A, Waldvogel HJ, MacDonald ME, Gusella JF, Bawden CS, Faull RL, Snell RG. (2013)
J Huntingtons Dis. 2013;2(3):279-95.

More info on PubMed.gov
Back To Top